Skip to content

Dietary Iron Requirements

Dietary Iron Requirements in US Adults

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07139821
Enrollment
300
Registered
2025-08-24
Start date
2026-02-06
Completion date
2029-05-31
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron Absorption

Keywords

Iron absorption, Iron losses, Iron requirements, Iron deficiency, Iron deficiency anemia, Iron isotopes

Brief summary

Dietary Reference Intakes (DRIs) for iron are based on a relatively small number of studies in European populations. This research study will determine iron needs in a representative sample of adults living in the US using the iron isotope dilution technique. Following administration and equilibration of a stable iron isotope, participants will be followed for a 12 week study period. Blood will be collected every 4 weeks and the isotopic composition will be determined. Results will help update dietary iron guidelines making sure they better match the specific needs of the US population.

Interventions

OTHERStable iron isotope

Stable iron isotopes will be used to determine iron requirements.

Sponsors

Pennington Biomedical Research Center
Lead SponsorOTHER
Cornell University
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Males and premenopausal females age 18-50 y * Previously participated in an iron stable isotope study or willing to consume an oral stable iron isotope and undergo a one-year equilibration period * Willing to refrain from iron-containing supplements for the duration of the study * Willing to refrain from tobacco smoking for the duration of the study * Have not donated blood 3 months prior to the start of the study and willing to refrain from donating blood for the duration of the study * Willing to have blood stored for future use * Able and willing to comply with study requirements and consent to participate

Exclusion criteria

* Females: pregnant or lactating or plans to become pregnant during the study period * Inability to provide informed consent and engage in informed consent procedures * Plans to relocate outside the study area

Design outcomes

Primary

MeasureTime frameDescription
Iron isotope composition in blood12 weeksTracer-to-tracee rate in venous blood samples collected at multiple time points

Countries

United States

Contacts

CONTACTStephen Hennigar, PhD
stephen.hennigar@pbrc.edu225-763-2612

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026